H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX) Mar 6, 2026 09:00AM
Lineage Cell Therapeutics outlines 2025 achievements and 2026 plans Jan 5, 2026 08:04AM
Lineage Cell Therapeutics (LCTX) Misses Q3 EPS by 11c Nov 6, 2025 04:54PM
Baird on Lineage Cell Therapeutics Inc. (LCTX): 'Incrementally positive following partner's R&D Day' Sep 23, 2025 02:20PM
H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX) Sep 9, 2025 06:51AM


Aug 26, 2025 08:03AM Lineage partners with William Demant Invest on hearing loss therapy
Aug 12, 2025 04:02PM Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 10c, Beats on Revenue
Jun 23, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)
May 13, 2025 04:04PM Lineage Cell Therapeutics (LCTX) Tops Q1 EPS by 1c
Mar 11, 2025 09:05AM Lineage Cell Therapeutics Inc. (LCTX) PT Lowered to $3 at Craig-Hallum
Mar 10, 2025 04:11PM Lineage Cell Therapeutics (LCTX) Tops Q4 EPS by 2c
Jan 6, 2025 08:02AM Lineage Cell Therapeutics (LCTX) Issues Letter to Stockholders
Dec 4, 2024 06:49AM Lineage Cell Therapeutics Inc. (LCTX) PT Raised to $9 at H.C. Wainwright
Nov 20, 2024 08:01AM Lineage Cell Therapeutics (LCTX) Prices Up to $66M Share and Warrant Offering
Nov 18, 2024 07:01AM D. Boral Capital Starts Lineage Cell Therapeutics Inc. (LCTX) at Buy
Oct 1, 2024 06:44AM Baird Reiterates Outperform Rating on Lineage Cell Therapeutics Inc. (LCTX)
Aug 20, 2024 09:13AM Craig-Hallum Starts Lineage Cell Therapeutics Inc. (LCTX) at Buy
Aug 8, 2024 04:42PM Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 3c